Pharmaceutical - Asia-Pacific, Takeda Pharmaceuticals

Filter

Popular Filters

Otsuka and Takeda to co-promote TAK-438 in the GI therapy area in Japan

Otsuka and Takeda to co-promote TAK-438 in the GI therapy area in Japan

29-03-2014

Japanese drugmakers Otsuka Pharmaceutical and Takeda Pharmaceutical have entered into a co-promotion…

Asia-PacificGastro-intestinalsJapanLicensingMarkets & MarketingOtsukaPharmaceuticalTAK-438Takeda Pharmaceuticalsvonoprazan

Takeda files for diabetes drug trelagliptin succinate approval in Japan

Takeda files for diabetes drug trelagliptin succinate approval in Japan

09-03-2014

Takeda Pharmaceutical, Japan’s largest drugmaker, has submitted a New Drug Application to the Japanese…

Asia-PacificBlopressCardio-vascularDiabetesJapanPharmaceuticalRegulationResearchTakeda Pharmaceuticalstrelagliptin

Takeda re-aligns marketing system in Japan

24-02-2014

Japan’s largest drugmaker Takeda Pharmaceutical says it decided to re-align its marketing system in…

Asia-PacificJapanManagementMarkets & MarketingPharmaceuticalTakeda Pharmaceuticals

Takeda to sell BIKEN varicella vaccine in Japan

Takeda to sell BIKEN varicella vaccine in Japan

15-01-2014

Japan’s largest drugmaker Takeda Pharmaceutical says it has reached agreement with the Research Foundation…

Asia-PacificMarkets & MarketingPharmaceuticalTakeda PharmaceuticalsVaccines

Takeda's vedolizumab enters Ph III in Japan for UC and Crohn's disease

Takeda's vedolizumab enters Ph III in Japan for UC and Crohn's disease

08-01-2014

Japan’s largest drugmaker Takeda Pharmaceutical revealed today that vedolizumab), an investigational…

Asia-PacificGastro-intestinalsPharmaceuticalResearchTakeda Pharmaceuticalsvedolizumab

Takeda to commercialize Teva’s glatiramer acetate for MS in Japan

Takeda to commercialize Teva’s glatiramer acetate for MS in Japan

05-12-2013

Revealing an earlier agreement yesterday, Israel’s Teva Pharmaceutical Industries and Japan’s largest…

Asia-PacificCopaxoneGlatiramer AcetateLicensingNeurologicalPharmaceuticalRegulationTakeda PharmaceuticalsTeva Pharmaceutical Industries

Takeda partners with newly-formed Tri-1 TDI

Takeda partners with newly-formed Tri-1 TDI

07-10-2013

The USA’s Memorial Sloan-Kettering Cancer Center, The Rockefeller University and Weill Cornell Medical…

Asia-PacificFinancialNorth AmericaPharmaceuticalResearchTakeda Pharmaceuticals

Indication changes for Glufast approved in Japan

13-09-2013

Japanese drugmakers Kissei Pharmaceutical (TYO: 4547) and Takeda Pharmaceutical (TYO: 4502) have received…

Asia-PacificDiabetesGlufastKissei PharmaceuticalPharmaceuticalRegulationTakeda Pharmaceuticals

Takeda gains Chinese approval for diabetes drug

31-07-2013

Japan's largest drugmaker, Takeda Pharmaceutical (TYO: 4502), says that the China Food and Drug Administration…

Asia-PacificDiabetesNesinaPharmaceuticalRegulationSanofiTakeda Pharmaceuticals

Disappointment for Takeda as Ph III prostate cancer trial fails

29-07-2013

Japan's largest drugmaker Takeda Pharma (TYO: 4502) has unblinded a Phase III study after analysis showed…

Asia-PacificMen's HealthOncologyorteronelPharmaceuticalResearchTakeda Pharmaceuticals

Evolution of Japan's pharma wholesalers - by P Reed Maurer

03-07-2013

Half of the definition for evolution (noun; a gradual process in which something changes especially into…

Asia-PacificFinancialMitsubishi TanabePharmaceuticalProductionSankyoShionogiTakeda Pharmaceuticals

Japan briefs: Takeda files for Azilva comb; Sandoz seeks filgrastim biosimilar approval

29-04-2013

Japan's largest drugmaker Takeda Pharmaceutical (TYO: 4502) says that it submitted a New Drug Application…

Amlodipine BesylateAsia-PacificAzilvaBiotechnologyCardio-vascularEP2006FilgrastimGenericsImmunologicalsNovartisPharmaceuticalRegulationSandozTakeda PharmaceuticalsZarzio

MHLW joins Japan's first P-PP to facilitate R&D of new health technologies for the developing world

08-04-2013

The Japanese Ministry of Health, Labor and Welfare (MHLW) has said it supports the research and development…

Asia-PacificAstellas PharmaDaiichi SankyoEisaiFinancialHealthcarePharmaceuticalResearchShionogiTakeda PharmaceuticalsTropical diseases

Takeda files for brentuximab vedotin approval in Japan; sanctioned by JPMA

22-03-2013

Japan's largest drugmaker, Takeda Pharmaceutical (TYO: 4502) and its oncology subsidiary Millennium have…

AdcetrisAlinamin-F5Asia-PacificbrentuximabMillennium LaboratoriesOncologyPharmaceuticalRegulationSeattle GeneticsTakeda Pharmaceuticals

Takeda called on to take corrective action over Alinamin-F5 marketing and manufacturing

15-02-2013

Japan's largest drugmaker Takeda Pharmaceutical (TYO: 4502) revealed it has received an Order for Corrective…

Alinamin-F5Asia-PacificPharmaceuticalProductionRegulationTakeda Pharmaceuticals

Takeda's leadership as Japan's largest drugmaker set to decline, says DR

29-10-2012

Based on full-year 2011 sales, Japan's Takeda Pharmaceutical (TYO: 4502) maintained its position as the…

Asia-PacificAstellas PharmaFinancialPharmaceuticalResearchTakeda Pharmaceuticals

Pharmaceutical majors unite in Japan to combat H. pylori

18-09-2012

On August 31, nine pharmaceutical companies operating in Japan (Kyowa Hakko Kirin, Takeda Pharmaceutical,…

Antibiotics and Infectious diseasesAsia-PacificAstraZenecaGastro-intestinalsPharmaceuticalRegulationTakeda Pharmaceuticals

Takeda loses distribution of 13 Pfizer products in Japan

19-06-2012

Japan's largest drugmaker, Takeda Pharmaceutical (TYO: 4502) has concluded an agreement that, as of December…

Asia-PacificBenefixEnbrelLicensingMarkets & MarketingPfizerPharmaceuticalPrevenarTakeda Pharmaceuticals

Takeda transfers Alzheimer's type dementia drug candidate TAK-070 to Tokyo university

11-06-2012

Japan's largest drugmaker Takeda Pharmaceutical (TYO: 4502) says that it has finalized a contract to…

Asia-PacificLicensingNeurologicalPharmaceuticalResearchTAK-070Takeda Pharmaceuticals

Takeda sets up development center in China

13-02-2012

Japan’s largest drugmaker, Takeda Pharmaceutical (TYO 4502), says it is establishing the Takeda…

Asia-PacificPharmaceuticalResearchTakeda Pharmaceuticals

Takeda to drop peginesatide commercialization in Japan

19-12-2011

Japan’s largest drugmaker Takeda Pharmaceutical (TYO: 4502) has decided not to commercialize peginesatide…

AffymaxAsia-PacificLicensingNephrology and HepatologypeginesatidePharmaceuticalTakeda Pharmaceuticals

Back to top